-
PurposeER targeted transmembrane domain with monomeric EGFP oriented towards the cytoplasm. Used for assessing fluorescent protein oligomerization.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 62237 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneclontech N1
-
Backbone manufacturerclontech
- Backbone size w/o insert (bp) 4000
- Total vector size (bp) 4900
-
Vector typeMammalian Expression
-
Selectable markersGentamicin
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCyTERM-mGFP
-
SpeciesSynthetic; rabbit
-
Insert Size (bp)936
-
Mutationsignal anchor of rabbit cytochrome p450 and monomerized EGFP
- Promoter CMV
-
Tag
/ Fusion Protein
- mGFP
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer tggtttagtgaaccgt
- 3′ sequencing primer GTTCAGGGGGAGGTGTG (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Used for assessing the likelihood of a fluorescent protein to oligomerize in cells. This is the monomeric control protein that does NOT form Organized Smooth Endoplasmic Reticulum (OSER) structures.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CyTERM-mGFP was a gift from Erik Snapp (Addgene plasmid # 62237 ; http://n2t.net/addgene:62237 ; RRID:Addgene_62237) -
For your References section:
Assessing the tendency of fluorescent proteins to oligomerize under physiologic conditions. Costantini LM, Fossati M, Francolini M, Snapp EL. Traffic. 2012 May;13(5):643-9. doi: 10.1111/j.1600-0854.2012.01336.x. Epub 2012 Feb 20. 10.1111/j.1600-0854.2012.01336.x PubMed 22289035